VideoVisit: Finnish virtual-care startup sells to Main Capital for Nordic buy-and-build

VideoVisit makes a virtual-care platform for municipalities: remote home care, primary care, rehabilitation and disability services over video.

Finnish digital-health company VideoVisit built a platform designed to digitalise healthcare and social care visits — primary care, home care, home rehabilitation and disability services — anchored on Finnish municipal customers.

In April 2022, Dutch software investor Main Capital Partners acquired VideoVisit as its first investment in the Finnish market, planning complementary solutions for existing customers, partnerships and selective buy-and-build acquisitions; Main pointed to healthcare experience from portfolio companies SDB Group, Enovation and Alfa eCare.

VideoVisit became Main Capital's Finnish platform: growth was to come from selling more solutions to its municipal base and rolling up adjacent virtual-care businesses. Terms were not disclosed.

VideoVisit digitised the highest-cost corner of healthcare — elderly home care — where each video visit returns nurses' travel time to patients who truly need hands-on care.

Over 50% of visits were medication-adherence checks: a repeatable, cost-saving use case rather than novelty teleconsultation.

Municipal contracts gave sticky, referenceable revenue; Helsinki, Espoo, Vantaa, Tampere and Turku served as proof for every other Finnish city.

Main Capital bought a platform, not just a product — its stated plan was buy-and-build consolidation alongside healthcare portfolio companies it already ran in Benelux and the Nordics.

For public-sector SaaS, a broad municipal customer base is the asset a buy-and-build investor pays for: sticky, referenceable renewals become the platform for rolling up a fragmented market.

As of the 20 April 2022 announcement, VideoVisit operated under Main Capital with deal terms undisclosed; growth was planned through complementary solutions for its 200+ municipal customers, partnerships and selective acquisitions. The 85% cost-efficiency figure was management's own claim, and the article carried no post-deal results.